IPF with preserved FVC — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Discuss antifibrotic therapy and supportive care in an ILD MDT
Antifibrotic therapy should be discussed in confirmed IPF, including patients with preserved FVC depending on current NICE eligibility, alongside supportive care and monitoring. Waiting for severe decline loses the opportunity to slow progression. Routine high-dose corticosteroids are not recommended for stable IPF.
Reference: NICE CG163; NICE TA864/TA379/TA504 for IPF antifibrotics